Given these functions and a dependency of BRCA1/2-deficient cancer cells on Tankyrase (McCabe et al., 2009), Tankyrase is a promising anti-cancer target (Haikarainen et al., 2014, Lehtiö et al., 2013, Riffell et al., 2012). Here, TNKS is linked to cancer.